Stay updated on Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page.

Latest updates to the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAdded a consolidated Locations section and removed the Belfast Locations, Inverness Locations, Kent Locations, and Northumberland Locations headings, with these sites now listed under the new section.SummaryDifference0.4%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.3.2 added and v3.3.1 removed; no changes to the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.1. The previous PubMed-related description and reference to revision v3.2.0 were removed.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the government funding status notice from the page, eliminating the funding-related disclaimer that could affect perceived data currency. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check58 days agoChange DetectedThe two screenshots reflect only visual/formatting updates with no change to core study content such as design, endpoints, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check86 days agoChange DetectedAdded a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old v3.1.0 version tag.SummaryDifference3%

Stay in the know with updates to Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page.